These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24919804)

  • 101. Genetic association and single-cell transcriptome analyses reveal distinct features connecting autoimmunity with cancers.
    Li S; Lu C; Zhang Y; Zhao X; Lin K; Kong X; Fox D; Xue L; Sun L; Liu Y; Mao F
    iScience; 2022 Jul; 25(7):104631. PubMed ID: 35800769
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Post-Translational Modifications of Proteins in Cytosolic Nucleic Acid Sensing Signaling Pathways.
    Deng Y; Wang Y; Li L; Miao EA; Liu P
    Front Immunol; 2022; 13():898724. PubMed ID: 35795661
    [TBL] [Abstract][Full Text] [Related]  

  • 103. A Random Walk-Based Method to Identify Candidate Genes Associated With Lymphoma.
    Sheng M; Cai H; Yang Q; Li J; Zhang J; Liu L
    Front Genet; 2021; 12():792754. PubMed ID: 34899868
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Topical Application of Temperature-Sensitive Gel Containing Caerin 1.1 and 1.9 Peptides on TC-1 Tumour-Bearing Mice Induced High-Level Immune Response in the Tumour Microenvironment.
    Ni G; Liu X; Li H; Fogarty CE; Chen S; Zhang P; Liu Y; Wu X; Wei MQ; Chen G; Zhang P; Wang T
    Front Oncol; 2021; 11():754770. PubMed ID: 34858827
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Reactivities of the Front Pocket N-Terminal Cap Cysteines in Human Kinases.
    Liu R; Zhan S; Che Y; Shen J
    J Med Chem; 2022 Jan; 65(2):1525-1535. PubMed ID: 34647463
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Therapeutic Potential of Regorafenib-A Multikinase Inhibitor in Pulmonary Hypertension.
    Veeroju S; Kojonazarov B; Weiss A; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Novoyatleva T; Schermuly RT
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540939
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia.
    Creeden JF; Alganem K; Imami AS; Henkel ND; Brunicardi FC; Liu SH; Shukla R; Tomar T; Naji F; McCullumsmith RE
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233470
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Tyrosine kinase inhibition to improve anthracycline-based chemotherapy efficacy in T-cell lymphoma.
    Magni M; Biancon G; Rizzitano S; Cavanè A; Paolizzi C; Dugo M; Corradini P; Carniti C
    Br J Cancer; 2019 Oct; 121(7):567-577. PubMed ID: 31474759
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Phase I/II study of dasatinib and exploratory genomic analysis in relapsed or refractory non-Hodgkin lymphoma.
    Umakanthan JM; Iqbal J; Batlevi CL; Bouska A; Smith LM; Shostrom V; Nutsch H; William BM; Gregory Bociek R; Lunning M; Bierman P; Younes A; Armitage JO; Vose JM
    Br J Haematol; 2019 Mar; 184(5):744-752. PubMed ID: 30520026
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Large-scale computational drug repositioning to find treatments for rare diseases.
    Govindaraj RG; Naderi M; Singha M; Lemoine J; Brylinski M
    NPJ Syst Biol Appl; 2018; 4():13. PubMed ID: 29560273
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell Lymphoma.
    Ion A; Popa IM; Papagheorghe LM; Lisievici C; Lupu M; Voiculescu V; Caruntu C; Boda D
    Dis Markers; 2016; 2016():9602472. PubMed ID: 27821903
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets.
    Saulite I; Hoetzenecker W; Weidinger S; Cozzio A; Guenova E; Wehkamp U
    Biomed Res Int; 2016; 2016():9717530. PubMed ID: 27294147
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma.
    Ratner L; Rauch D; Abel H; Caruso B; Noy A; Barta SK; Parekh S; Ramos JC; Ambinder R; Phillips A; Harding J; Baydoun HH; Cheng X; Jacobson S
    Blood Cancer J; 2016 Mar; 6(3):e408. PubMed ID: 27015285
    [No Abstract]   [Full Text] [Related]  

  • 114. Bakuchiol suppresses proliferation of skin cancer cells by directly targeting Hck, Blk, and p38 MAP kinase.
    Kim JE; Kim JH; Lee Y; Yang H; Heo YS; Bode AM; Lee KW; Dong Z
    Oncotarget; 2016 Mar; 7(12):14616-27. PubMed ID: 26910280
    [TBL] [Abstract][Full Text] [Related]  

  • 115. LMO2 Oncoprotein Stability in T-Cell Leukemia Requires Direct LDB1 Binding.
    Layer JH; Alford CE; McDonald WH; Davé UP
    Mol Cell Biol; 2016 Feb; 36(3):488-506. PubMed ID: 26598604
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Ectopic expression of embryonic stem cell and other developmental genes in cutaneous T-cell lymphoma.
    Litvinov IV; Netchiporouk E; Cordeiro B; Zargham H; Pehr K; Gilbert M; Zhou Y; Moreau L; Woetmann A; Ødum N; Kupper TS; Sasseville D
    Oncoimmunology; 2014 Nov; 3(11):e970025. PubMed ID: 25941598
    [TBL] [Abstract][Full Text] [Related]  

  • 117. The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL).
    Litvinov IV; Netchiporouk E; Cordeiro B; Doré MA; Moreau L; Pehr K; Gilbert M; Zhou Y; Sasseville D; Kupper TS
    Clin Cancer Res; 2015 Jun; 21(12):2820-9. PubMed ID: 25779945
    [TBL] [Abstract][Full Text] [Related]  

  • 118. B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL).
    Petersen DL; Krejsgaard T; Berthelsen J; Fredholm S; Willerslev-Olsen A; Sibbesen NA; Bonefeld CM; Andersen MH; Francavilla C; Olsen JV; Hu T; Zhang M; Wasik MA; Geisler C; Woetmann A; Odum N
    Leukemia; 2014 Oct; 28(10):2109-12. PubMed ID: 24919804
    [No Abstract]   [Full Text] [Related]  

  • 119. Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.
    Krejsgaard T; Vetter-Kauczok CS; Woetmann A; Kneitz H; Eriksen KW; Lovato P; Zhang Q; Wasik MA; Geisler C; Ralfkiaer E; Becker JC; Ødum N
    Blood; 2009 Jun; 113(23):5896-904. PubMed ID: 19351960
    [TBL] [Abstract][Full Text] [Related]  

  • 120. A novel BLK-induced tumor model.
    Petersen DL; Berthelsen J; Willerslev-Olsen A; Fredholm S; Dabelsteen S; Bonefeld CM; Geisler C; Woetmann A
    Tumour Biol; 2017 Jul; 39(7):1010428317714196. PubMed ID: 28670978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.